The CAVITAT™ is a unique patented computerized 3-D color imaging device capable of detecting and measuring low bone density areas of the maxillofacial (jawbone) bones.
As stated in the CAVITAT™ Medical Technologies, Inc. brochure, low density lesions can and do produce debilitating toxins and are often located in old extraction sites and under or near roots or root canal teeth, avital teeth and wisdom teeth. Sometimes the lesions spread extensively from these locations throughout the jawbone and may penetrate the sinuses or totally encompass the mandibular nerve unobservable in other imaging systems until 50% or more of the cortical bone is destroyed.
The term “osteonecrosis” has been used not only to describe those lesions appearing as empty holes, but also other types of lesions in the jawbone. These lesions have been found through tissue analysis to be ischemic (lacking in blood flow), necrotic (dead), osteo-myelitic (bone infected), gangrenous and very toxic.
In my dissertation paper for my Doctor of Integrative Medicine at Capital University of Washington, DC, “Accurate Detection of Jawbone Lesions and Osteolytic Abnormalities sing CAVITAT™ Ultrasonogram Imaging System: A Clinical Study Utilizing Photoaffinity Labeling and Histological Assessments”. My results were utilized in achieving FDA Clearance of the CAVITAT™ for clinical use.